160 related articles for article (PubMed ID: 11602139)
1. [Treatment of opportunistic infections among adult and adolescent patients infected with the human immunodeficiency virus in the era of highly active anti-retroviral therapy].
Podzamczer D; Ramón Arribas J; Mallolas J; María Peña J; Pulido F;
Enferm Infecc Microbiol Clin; 2001 Oct; 19(8):376-92. PubMed ID: 11602139
[No Abstract] [Full Text] [Related]
2. Summaries for patients. Can maintenance therapy for opportunistic infections in HIV-infected people be stopped safely?
Ann Intern Med; 2002 Aug; 137(4):I34. PubMed ID: 12186538
[No Abstract] [Full Text] [Related]
3. [Prevention of opportunistic infections in adult and adolescent patients infected with the human immunodeficiency virus in the era of highly active antiretroviral therapy. Recommendations of the Grupo de Estudio del SIDA (GESIDA/Plan National sobre el SIDA].
Berenguer J; Laguna F; López-Aldeguer J; Moreno S
Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):457-68. PubMed ID: 11149170
[No Abstract] [Full Text] [Related]
4. Update on opportunistic infections in the era of effective antiretroviral therapy.
Zanoni BC; Gandhi RT
Infect Dis Clin North Am; 2014 Sep; 28(3):501-18. PubMed ID: 25151568
[TBL] [Abstract][Full Text] [Related]
5. HIV: opportunistic infections.
Ioannidis J; Wilkinson D
Clin Evid; 2003 Jun; (9):795-816. PubMed ID: 15366175
[No Abstract] [Full Text] [Related]
6. Drug treatment of HIV-related opportunistic infections.
Klepser ME; Klepser TB
Drugs; 1997 Jan; 53(1):40-73. PubMed ID: 9010648
[TBL] [Abstract][Full Text] [Related]
7. Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.
Kirk O; Reiss P; Uberti-Foppa C; Bickel M; Gerstoft J; Pradier C; Wit FW; Ledergerber B; Lundgren JD; Furrer H;
Ann Intern Med; 2002 Aug; 137(4):239-50. PubMed ID: 12186514
[TBL] [Abstract][Full Text] [Related]
8. Short Communication: Mycobacterium avium Complex Infection and Immune Reconstitution Inflammatory Syndrome Remain a Challenge in the Era of Effective Antiretroviral Therapy.
Smibert OC; Trubiano JA; Cross GB; Hoy JF
AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1202-1204. PubMed ID: 28791872
[TBL] [Abstract][Full Text] [Related]
9. Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy.
Portilla J; Boix V; Román F; Reus S; Merino E
J Infect; 2000 Sep; 41(2):182-4. PubMed ID: 11023768
[TBL] [Abstract][Full Text] [Related]
10. Opportunistic infections update.
Proj Inf Perspect; 1998 Apr; (24):17-9. PubMed ID: 11365715
[TBL] [Abstract][Full Text] [Related]
11. AIDS related opportunistic infections, going but not gone.
Samuel R; Bettiker RL; Suh B
Arch Pharm Res; 2002 Jun; 25(3):215-28. PubMed ID: 12135090
[TBL] [Abstract][Full Text] [Related]
12. Update on opportunistic infections.
Bartlett JG
Hopkins HIV Rep; 2002 May; 14(3):9. PubMed ID: 12206102
[No Abstract] [Full Text] [Related]
13. Progressive multifocal leukoencephalopathy successfully treated with highly active antiretroviral therapy and cidofovir in an adolescent infected with perinatal human immunodeficiency virus (HIV).
Robinson LG; Chiriboga CA; Champion SE; Ainyette I; DiGrado M; Abrams EJ
J Child Neurol; 2004 Jan; 19(1):35-8. PubMed ID: 15032381
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of common HIV-associated opportunistic complications.
Carmichael C
Prim Care; 1997 Sep; 24(3):561-74. PubMed ID: 9271692
[TBL] [Abstract][Full Text] [Related]
15. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterial diseases and HIV.
Pozniak A
J HIV Ther; 2002 Feb; 7(1):13-6. PubMed ID: 11956499
[TBL] [Abstract][Full Text] [Related]
17. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
Hall CD; Dafni U; Simpson D; Clifford D; Wetherill PE; Cohen B; McArthur J; Hollander H; Yainnoutsos C; Major E; Millar L; Timpone J
N Engl J Med; 1998 May; 338(19):1345-51. PubMed ID: 9571254
[TBL] [Abstract][Full Text] [Related]
18. HIV: prevention of opportunistic infections.
Ioannidis J; Wilkinson D
Clin Evid; 2003 Dec; (10):809-30. PubMed ID: 15555123
[No Abstract] [Full Text] [Related]
19. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
20. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C; ; ;
MMWR Recomm Rep; 2004 Dec; 53(RR-14):1-92. PubMed ID: 15577752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
